lOMoARcPSD|285 053 80
lOMoARcPSD|285 053 80
ATI Pharmacology Proctor 2026 final exam
1. What is/are the action(s) of the drug metformin?
a. Decreases Hepatic glucose production and intestinal glucose absorption
b. Increases sensitivity to insulin
c. Short term sedation
d. Both A and B - d. Both A and B
When administering the drug senna to a patient, a health care provider must
inform
2. the patient of which of the following
a. This drug is intended to lower blood pressure and is best used in combination
with other antihypertensives
b. This drug is not intended for long term use
c. The patient must limit his/her fiber intake
d. Advise patient to change positions slowly to limit the risk of orthostatic
hypotension - b. This drug is not intended for long term use
3. When giving digoxin (Lanoxin) to a patient, the health care provider notices
various signs and symptoms of an overdose. The health care provider knows to
give which of the following to reverse digoxin toxicity
a. Naloxone
b. Vitamin K
c. Digibind
d. Fluemanzil - c. Digibind
While providing an Angiotensin-converting enzyme (ACE) inhibitor, the patient
asks
4. what the action of the drug is. As a health care provider, you explain that the
action of an ACE inhibitor is
a. To lower blood pressure by blocking the conversion of angiotensin I
to vasoconstrictor angiotensin II
b. To inhibit reabsorption of sodium back into the body, ultimately increasing
urine output and lowering blood pressure
c. To decrease heart rate and blood pressure by competing with Beta1 and
Beta2 receptors in the heart and lungs
d. To lower blood glucose by stimulating the release of insulin - a. To lower blood
pressure by blocking the conversion of angiotensin I to vasoconstrictor
angiotensin II
, lOMoARcPSD|285 053 80
5. Which mof mthe mfollowing mtypes mof minsulin mis m"long-acting"? m
a. Lispro m(Humalog) m
b. NPH m(Humulin mN) m
c. Regular minsulin m(Humulin mR) m
d. Glargine m(Lantus) m- md. mGlargine m(Lantus) m
6. What mis mthe mtherapeutic muse mof mmetformin? mA. mLower mblood mpressure. m
B. To mdiminish mseizure mactivity. m
C. The mmaintenance mof ma mperson's mblood mglucose. m
D. Increase mheart mrate mand mdecrease mgastrointestinal msecretions. m- mC. mThe
mmaintenance mof ma mperson's mblood mglucose. m
m
1. What mis mthe mcorrect mdefinition mfor mabsorption mof ma mdrug? m
A. Movement mof mdrug mfrom msite mof madministration mto mvarious mtissues mof mthe
mbody. m
B. Describes mthe mabsorption, mdistribution, mmetabolism m& mexcretion mof
mdrugs. m
C. These mtypes mof mdrugs mcan mbe mtaken mover mthe mcounter. m
D. This maddresses mhow mvarious mdrugs maffect mdifferent mforms mof mthe mbody m-
mA. mMovement mof mdrug mfrom msite mof madministration mto mvarious mtissues mof
mthe mbody m
m
2. What mdo myou massess mfor min ma mpatient mwho mis mon mValproate? mSelect mall mthat
mapply. m
A. Suicidal mthoughts m
B. Monitor mfor mseizures. m
C. Bipolar mdisorder. m
D. Migraines. m
E. Anorexia m- mA. mSuicidal mthoughts m
7. B. mMonitor mfor mseizures. mC. mBipolar mdisorder. mE. mMigraines. m
m
8. What mis mtrue mabout mfood mand mdrug mprecautions? mSelect mall mthat mapply. m
A. You mmust mlimit mcertain mtypes mof mfood mor mconcurrent
madministration mof mcertain mtypes mof mdrugs. m
B. Certain mcombinations mof mfood mand mdrugs mcan mcause madverse
mreactions. mC. mPrecautions mmay mrequire mlimiting mcertain mtypes mof
mfood mor mconcurring mdrugs mrather mthan mrestricting mthe mdrug mitself.
m
C. When mone mdrug mchanges mthe mway, manother mdrug maffects mthat
mdrug. m- mA. mYou mmust mlimit mcertain mtypes mof mfood mor mconcurrent
madministration mof mcertain mtypes mof mdrugs. m
B. mCertain mcombinations mof mfood mand mdrugs mcan mcause madverse mreactions. mC.
mPrecautions mmay mrequire mlimiting mcertain mtypes mof mfood mor mconcurring mdrugs
mrather mthan mrestricting mthe mdrug mitself. m
m
9. ACE mInhibitors mare mused min mthe mtreatment mof mall mEXCEPT: m
a. Hypertension m
b. Heart mFailure m
, lOMoARcPSD|285 053 80
c. Hypotension m
d. Diabetic mnephropathy m- mc. mHypotension m
m
10. Which mof mthe mfollowing mis mused mto mtreat mmigraine mheadaches? m
a. Beta-blockers m
b. Cholinesterase mInhibitors m
c. ACE minhibitors m
d. mAnti-epileptic mdrugs m(AEDs) m- ma. mBeta-blockers m
m
11. When madministering ma mSerotonin mAntagonist mit mis mimportant mto mmonitor mfor m
a. Intake mand moutput m
b. Mental mstatus mchanges m
c. Respiratory mrate m
d. Anorexia m- mb. mMental mstatus mchanges m
m
12. Which mof mthe mfollowing mis mthe mantidote mfor mHeparin? m
a. Protamine msulfate m
b. Vitamin mK m
c. Naloxone m
d. Toradol m- ma. mProtamine msulfate m
m
13. A mpatient mhas mbeen mtaking mhydrocodone, mand mopioid manalgesic mfor mtheir
mmoderate mpain, mand mthey mhave mtaken mover mtheir mprescribed mdose. mWhat
mshould myou mgive mas mthe mantidote mif mthey mexperience mtoxicity? m
A. Naloxone m
B. N-acetylcysteine m
C. Atropine m
D. Digoxin mimmune mFab m- mA. mNaloxone m
m
14.A mA mpatient mis mbeing meducated mon mtaking mlevothyroxine, ma mdrug mused mto
mbalance mthyroid mactivity. mWhat mshould myou minclude min mtheir meducation? m
A. Don't mbother myour mhealth mcare mprofessionals mif myou mexperience
mside meffects m
B. Take mthis mat mthe msame mtime mevery mday m
C. Thyroid mtests mare munnecessary mwhile mtaking mthis mdrug m
D. It mis mokay mto mtake mthis mdrug mif myou mhave mrecently mhad ma
mmyocardial minfarction m- mB. mTake mthis mat mthe msame mtime mevery
mday m
m
15.A mA mpatient mstates mhe mexperiences manxiety mand mhas mpanic mattacks mat mleast
monce ma mweek. mWhat mmight mbe mhelpful mfor mthis mpatient? m
A. Phenytoin m(Dilantin) m
B. Lithium m
C. Alprazolam m(Xanax) m
D. Spironolactone m- mC. mAlprazolam m(Xanax) m
m
lOMoARcPSD|285 053 80
ATI Pharmacology Proctor 2026 final exam
1. What is/are the action(s) of the drug metformin?
a. Decreases Hepatic glucose production and intestinal glucose absorption
b. Increases sensitivity to insulin
c. Short term sedation
d. Both A and B - d. Both A and B
When administering the drug senna to a patient, a health care provider must
inform
2. the patient of which of the following
a. This drug is intended to lower blood pressure and is best used in combination
with other antihypertensives
b. This drug is not intended for long term use
c. The patient must limit his/her fiber intake
d. Advise patient to change positions slowly to limit the risk of orthostatic
hypotension - b. This drug is not intended for long term use
3. When giving digoxin (Lanoxin) to a patient, the health care provider notices
various signs and symptoms of an overdose. The health care provider knows to
give which of the following to reverse digoxin toxicity
a. Naloxone
b. Vitamin K
c. Digibind
d. Fluemanzil - c. Digibind
While providing an Angiotensin-converting enzyme (ACE) inhibitor, the patient
asks
4. what the action of the drug is. As a health care provider, you explain that the
action of an ACE inhibitor is
a. To lower blood pressure by blocking the conversion of angiotensin I
to vasoconstrictor angiotensin II
b. To inhibit reabsorption of sodium back into the body, ultimately increasing
urine output and lowering blood pressure
c. To decrease heart rate and blood pressure by competing with Beta1 and
Beta2 receptors in the heart and lungs
d. To lower blood glucose by stimulating the release of insulin - a. To lower blood
pressure by blocking the conversion of angiotensin I to vasoconstrictor
angiotensin II
, lOMoARcPSD|285 053 80
5. Which mof mthe mfollowing mtypes mof minsulin mis m"long-acting"? m
a. Lispro m(Humalog) m
b. NPH m(Humulin mN) m
c. Regular minsulin m(Humulin mR) m
d. Glargine m(Lantus) m- md. mGlargine m(Lantus) m
6. What mis mthe mtherapeutic muse mof mmetformin? mA. mLower mblood mpressure. m
B. To mdiminish mseizure mactivity. m
C. The mmaintenance mof ma mperson's mblood mglucose. m
D. Increase mheart mrate mand mdecrease mgastrointestinal msecretions. m- mC. mThe
mmaintenance mof ma mperson's mblood mglucose. m
m
1. What mis mthe mcorrect mdefinition mfor mabsorption mof ma mdrug? m
A. Movement mof mdrug mfrom msite mof madministration mto mvarious mtissues mof mthe
mbody. m
B. Describes mthe mabsorption, mdistribution, mmetabolism m& mexcretion mof
mdrugs. m
C. These mtypes mof mdrugs mcan mbe mtaken mover mthe mcounter. m
D. This maddresses mhow mvarious mdrugs maffect mdifferent mforms mof mthe mbody m-
mA. mMovement mof mdrug mfrom msite mof madministration mto mvarious mtissues mof
mthe mbody m
m
2. What mdo myou massess mfor min ma mpatient mwho mis mon mValproate? mSelect mall mthat
mapply. m
A. Suicidal mthoughts m
B. Monitor mfor mseizures. m
C. Bipolar mdisorder. m
D. Migraines. m
E. Anorexia m- mA. mSuicidal mthoughts m
7. B. mMonitor mfor mseizures. mC. mBipolar mdisorder. mE. mMigraines. m
m
8. What mis mtrue mabout mfood mand mdrug mprecautions? mSelect mall mthat mapply. m
A. You mmust mlimit mcertain mtypes mof mfood mor mconcurrent
madministration mof mcertain mtypes mof mdrugs. m
B. Certain mcombinations mof mfood mand mdrugs mcan mcause madverse
mreactions. mC. mPrecautions mmay mrequire mlimiting mcertain mtypes mof
mfood mor mconcurring mdrugs mrather mthan mrestricting mthe mdrug mitself.
m
C. When mone mdrug mchanges mthe mway, manother mdrug maffects mthat
mdrug. m- mA. mYou mmust mlimit mcertain mtypes mof mfood mor mconcurrent
madministration mof mcertain mtypes mof mdrugs. m
B. mCertain mcombinations mof mfood mand mdrugs mcan mcause madverse mreactions. mC.
mPrecautions mmay mrequire mlimiting mcertain mtypes mof mfood mor mconcurring mdrugs
mrather mthan mrestricting mthe mdrug mitself. m
m
9. ACE mInhibitors mare mused min mthe mtreatment mof mall mEXCEPT: m
a. Hypertension m
b. Heart mFailure m
, lOMoARcPSD|285 053 80
c. Hypotension m
d. Diabetic mnephropathy m- mc. mHypotension m
m
10. Which mof mthe mfollowing mis mused mto mtreat mmigraine mheadaches? m
a. Beta-blockers m
b. Cholinesterase mInhibitors m
c. ACE minhibitors m
d. mAnti-epileptic mdrugs m(AEDs) m- ma. mBeta-blockers m
m
11. When madministering ma mSerotonin mAntagonist mit mis mimportant mto mmonitor mfor m
a. Intake mand moutput m
b. Mental mstatus mchanges m
c. Respiratory mrate m
d. Anorexia m- mb. mMental mstatus mchanges m
m
12. Which mof mthe mfollowing mis mthe mantidote mfor mHeparin? m
a. Protamine msulfate m
b. Vitamin mK m
c. Naloxone m
d. Toradol m- ma. mProtamine msulfate m
m
13. A mpatient mhas mbeen mtaking mhydrocodone, mand mopioid manalgesic mfor mtheir
mmoderate mpain, mand mthey mhave mtaken mover mtheir mprescribed mdose. mWhat
mshould myou mgive mas mthe mantidote mif mthey mexperience mtoxicity? m
A. Naloxone m
B. N-acetylcysteine m
C. Atropine m
D. Digoxin mimmune mFab m- mA. mNaloxone m
m
14.A mA mpatient mis mbeing meducated mon mtaking mlevothyroxine, ma mdrug mused mto
mbalance mthyroid mactivity. mWhat mshould myou minclude min mtheir meducation? m
A. Don't mbother myour mhealth mcare mprofessionals mif myou mexperience
mside meffects m
B. Take mthis mat mthe msame mtime mevery mday m
C. Thyroid mtests mare munnecessary mwhile mtaking mthis mdrug m
D. It mis mokay mto mtake mthis mdrug mif myou mhave mrecently mhad ma
mmyocardial minfarction m- mB. mTake mthis mat mthe msame mtime mevery
mday m
m
15.A mA mpatient mstates mhe mexperiences manxiety mand mhas mpanic mattacks mat mleast
monce ma mweek. mWhat mmight mbe mhelpful mfor mthis mpatient? m
A. Phenytoin m(Dilantin) m
B. Lithium m
C. Alprazolam m(Xanax) m
D. Spironolactone m- mC. mAlprazolam m(Xanax) m
m
